Cancer immunosurveillance: NKG2D breaks cover.
The idea of cancer immunosurveillance has regained interest in recent years. In this issue of Immunity, Guerra et al. (2008) present the first genetic evidence for surveillance of primary tumors by a natural killer cell-associated receptor.